Search results

Jump to: navigation, search

Page title matches

Page text matches

  • -Formulate a broad definition of what biomarkers are, and provide guideline when custom domains are needed or when exisiting domains can or should be u
    4 KB (597 words) - 13:03, 27 August 2015
  • ...s/en_GB/document_library/Scientific_guideline/2010/09/WC500096793.pdf EMA: Guideline on Missing Data in Confirmatory Clinical Trials]
    5 KB (690 words) - 03:46, 10 April 2014
  • * Most companies with programming personnel have a document or guideline where they describe their good practices for deriving syntax. This document ...he GPP board is to achieve a consensus recommendations for a consolidated guideline which could potentially replace these documents.
    9 KB (1,356 words) - 04:38, 18 May 2018
  • *More description added to Guideline from public and FDA reviews *Improved consistency of template and guideline to SENDIG
    4 KB (560 words) - 06:47, 20 March 2018
  • :::::• Guideline from Agency
    7 KB (951 words) - 13:16, 11 April 2012
  • ...thus making it easier to read. No more than 80 characters wide is a good guideline for this.
    4 KB (587 words) - 09:46, 12 April 2016
  • *Guideline for Industry: Structure and Content of Clinical Study Reports
    4 KB (584 words) - 13:32, 30 October 2012
  • There is no special FDA guideline for drug approvals for Parkinson's Disease. ...u/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003540.pdf Guideline on Clinical Investigations of Medicinal Products in the Treatment of Parkin
    11 KB (1,585 words) - 00:59, 27 October 2016
  • ...cs/en_GB/document_library/Scientific_guideline/2009/09/WC500003540.pdf EMA guideline] mentions the UPDRS II and III scales as accepted scales to measure the eff
    7 KB (1,002 words) - 03:16, 8 June 2012
  • ...cs/en_GB/document_library/Scientific_guideline/2009/09/WC500003540.pdf EMA guideline] mentions HYS for staging the severity of PD for the study population. So H
    3 KB (424 words) - 03:34, 8 June 2012
  • #Nancy Everds, [[Media:CLSI.pdf]], a guideline for clinical reference interval generation
    3 KB (488 words) - 15:03, 23 July 2012
  • The guideline names new claims evaluated in clinical trials during drug development like ...ty may not be state of the art anymore. However, beside other sources this guideline is a good point to start digging deeper into RA trial methodology, especial
    24 KB (3,585 words) - 03:42, 15 January 2014
  • ::* Guideline from Agency
    1 KB (205 words) - 07:39, 13 October 2012
  • ::* Guideline from Agency
    1 KB (179 words) - 08:03, 13 October 2012
  • ...of GPP guidance within their company, usually not a SOP. Nevertheless, the guideline might be referenced from other SOPs.
    4 KB (652 words) - 05:23, 7 November 2012
  • [http://www.cdisc.org/extranet/index.php?a=3402 CDISC Metadata Submission Guideline (MSG)]<br />
    2 KB (270 words) - 18:15, 1 November 2012
  • ...h may also be due to the relative age of the guideline. All in all the FDA guideline leaves much room for interpretation on how a trial should be designed to be ...y available as second revision and was issued in 2010. This relatively new guideline gives a general overview on prevalence and aetiology of the disease as well
    14 KB (2,109 words) - 15:51, 10 November 2014
  • ...ionally describes potential issues. Programmers can use this document as a guideline to converting their programs.
    24 KB (3,868 words) - 09:28, 17 January 2013
  • *** Finalizing platform – overview, guideline, roles, duties, issue tracking (.5 h) – Hanming
    3 KB (384 words) - 09:25, 28 January 2013
  • *** Finalizing platform – overview, guideline, roles, duties, issue tracking (.5 h) – Hanming
    3 KB (420 words) - 09:24, 28 January 2013

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)